Variational AI applies its 𝐄𝐧𝐤𝐢™ generative AI platform to design novel PRMT6 inhibitor scaffolds and discover lead candidates. To ensure rapid execution and reduce downstream attrition, the ...

Variational Autoencoders (VAEs) are an artificial neural network architecture to generate new data. They are similar to regular autoencoders, which consist of an encoder and decoder. The encoder takes ...

VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / Variational AI, a leading innovator in generative artificial intelligence for drug discovery, is making headlines in biotech with a bold mission: ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...

VANCOUVER, British Columbia, September 23, 2025--(BUSINESS WIRE)--Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the ...

Variational AI CEO Handol Kim's company has a platform that uses the language of chemistry to create drug recipes | Rob Kruyt Multinational drug developer Merck is partnering with a Vancouver-based ...

A new framework for generative diffusion models was developed by researchers at Science Tokyo, significantly improving generative AI models. The method reinterpreted Schrödinger bridge models as ...